Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02924857 · ClinicalTrials.gov registry record · NA

The Chocolate Touch Study

A NA study of Intermittent Claudication and Ischemia, sponsored by TriReme Medical.

Active
Registry status
NA
Development phase
333
Enrollment target
20
Study locations

NCT02924857 is a NA study of Intermittent Claudication and Ischemia that is active but no longer recruiting, run by TriReme Medical. The registered enrollment target is 333 participants, above the 186-participant average among 11 other Intermittent Claudication trials with a reported enrollment target (79% higher). The trial reports 20 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02924857, a NA study of Intermittent Claudication and Ischemia, is active but no longer recruiting, sponsored by TriReme Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
333 participants
Enrollment target
20
Study locations

Study Summary

The Chocolate Touch study is a randomized, multi-center, prospective, adaptive study, designed to show sufficient safety and effectiveness of the Chocolate Touch™ for use in superficial femoral or popliteal arteries with the intention of obtaining regulatory approval to market this device in the United States

Conditions Studied

Intermittent Claudication Ischemia Peripheral Artery Disease (PAD)

Interventions

  • DEVICE Chocolate Touch
  • DEVICE Lutonix Drug Coated Balloon

Study Locations (20)

Other

  • Medical University of Graz - LKH Univ.-Klinikum Graz - Graz
  • Angiologie - Hansuchkrankenhaus - Vienna
  • Universitat Herz-Zentrum - Bad Krozingen
  • Auckland City Hospital - Auckland
  • Waikato Hospital - Hamilton

Pennsylvania

  • Penn State Health Holy Spirit Medical Center - Camp Hill
  • Pinnacle Health Cardiovascular Institute - Wormleysburg
  • Lankenau Medical Center - Wynnewood

Florida

  • Cardiac and Vascular Institute - Gainesville
  • Mt. Sinai - Miami - Miami Beach

New York

  • Mt. Sinai Heart - New York
  • Columbia University Medical Center / NewYork Presbyterian Hospital - New York

Georgia

  • Emory University - Atlanta

Louisiana

  • Cardiovascular Institute of the South - Houma

Michigan

  • Michigan Outpaitient Vascular Institution - Dearborn

Mississippi

  • Jackson Heart - Jackson

Trial Details

FieldValue
Enrollment Target 333 participants
Start Date 2017-07-26
Est. Completion 2026-12
Phase NA

Sponsor

TriReme Medical

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02924857

The ClinicalTrials.gov registry entry for NCT02924857 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 333 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 186-participant average among 11 other Intermittent Claudication trials with a reported enrollment target (79% higher). The listed sponsor is TriReme Medical, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Intermittent Claudication appearing as the primary indexed condition, and to 2 interventions - of which Chocolate Touch is the first listed.

NCT02924857 reports 20 study locations spanning 12 distinct geographic areas - top geographies include Other, Pennsylvania, Florida.

Frequently Asked Questions

What is clinical trial NCT02924857 about?

NCT02924857 is a clinical study titled "The Chocolate Touch Study". The Chocolate Touch study is a randomized, multi-center, prospective, adaptive study, designed to show sufficient safety and effectiveness of the Chocolate Touch™ for use in superficial femoral or popliteal arteries with the intention of obtaining regulatory approval to market this device in the Uni...

What is the current status of trial NCT02924857?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 333 participants. The study started on 2017-07-26. Estimated completion is 2026-12.

What conditions does trial NCT02924857 study?

This clinical trial studies the following conditions: Intermittent Claudication, Ischemia, Peripheral Artery Disease (PAD).

What interventions are being tested in trial NCT02924857?

The interventions under investigation include: Chocolate Touch (DEVICE), Lutonix Drug Coated Balloon (DEVICE).

Who is sponsoring clinical trial NCT02924857?

This trial is sponsored by TriReme Medical, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02924857 being conducted?

This trial has 20 study locations across Florida, Georgia, Louisiana, Michigan, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Intermittent Claudication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Intermittent Claudication

All registered trials for this condition

Ischemia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.